Merger and acquisition deal value in the pharmaceutical and life sciences sector increased in the first quarter of 2013 relative to the first quarter of 2012. The pharmaceutical segment recorded the largest gains in deal value during the quarter on the strength of several large transactions.
Transactions should trend at an active pace during 2013 as pharmaceutical and biotechnology companies seek acquisitions in select asset classes and medical device and diagnostics companies evaluate new growth strategies.
This issue of the Deals Insights Quarterly also focuses on the region of Southeast Asia and its five fastest-growing markets — Indonesia, Malaysia, the Philippines, Thailand, and Vietnam. Economic, political, and market factors in these countries have created an environment ripe with opportunity for investment.
This issue also focuses on the gap that frequently exists between price and value and highlights potential blind spots in the valuation of businesses and assets in transactions.